St3+ Hematology Clinical Fellowship

Job description

·  Job facts

Summary

The Roche Hematology Clinical Fellowship is aimed at UK Specialist Trainee Doctors (ST3+) who are undergoing Hematology specialist training within the NHS.This Programme are for thosewho have a strong interest in the area of clinical research into novel pharmaceuticals, including biologic therapies.

The Roche UK Clinical Research Fellowship was established in 2013 and is aimed at trainees who have an interest in diversifying and broadening their training to include various aspects of clinical research methodology from the perspective of novel pharmaceutical development.

The fellowship will be 1 year in duration, primarily based at Roche Products Ltd in Welwyn Garden City, UK, within the Oncology Clinical Development Group. There will be the opportunity for direct interaction across the global merged Roche and Genentech companies. Your research supervisor at Roche will be an experienced and fully UK accredited Physician working for Roche based in Welwyn Garden City, experienced in pharmaceutical research and clinical development as well as clinical medicine career development in the UK.

The Fellow will be expected to have a clinical commitment consistent with the requirements of being Out Of Program (OOP) in the context of specialty training, including having a clinical supervisor. It will be the responsibility of the Fellow to arrange this clinical activity.

As a Fellow in the Global Oncology Clinical Development Group you may:

· 
Be involved in the design, execution, analysis and interpretation of data from clinical studies for marketed compounds as well as molecules earlier in development

· 
Interact with globally recognized academic experts and clinical investigators

· 
Participate in key clinical strategy, implementation and molecule management meetings in order to gain a deeper understanding of the complexities and challenges of medicines development

· 
Provide clinical expertise in the Hematology disease areas for cross functional pharmaceutical development teams

· 
Generate and present abstracts and oral presentations for key external conferences (e.g., EHA, ASH, ASCO, ICML) and other specialty meetings as well as publication opportunities.

· 
Be involved in discussions of Personalized Health Care (PHC) and how patient selection for different therapeutic interventions can be improved

Who is the Roche Clinical Research Fellowship suitable for?

· 
Ideally a third or fourth year Hematology trainee looking to diversify their training

· 
A candidate with a track record in clinical research. An MSc or strong publication background is highly desirable but not essential.

· 
Someone interested in further understanding and influencing the development and approval of medicines for patients with blood and solid cancers.

Note: this is not intended to be a basic science fellowship leading to a post graduate degree, although the clinical research could supplement or inform existing basic research if appropriate.

Why a Pharmaceutical Industry Fellowship?

· 
Collaboration between pharmaceutical companies, the health service and academia is key to improving patient care

· 
Understanding of the drug development, regulation and reimbursement process is critical for physicians wanting to influence the delivery of healthcare

· 
This fellowship offers unique training for Hematology trainees wishing to participate or conduct clinical trials in their future careers

· 
Abundant scope for research opportunities within large impactful datasets and the chance to work with top key opinion leaders

Why Roche?

· 
Over many years Roche has generated large clinical databases from multiple randomized clinical trials and registries of patients with Hematology disease, and is a world leader in clinical research.

· 
Hematology seeking intensive training and publishing in clinical research, biostatistics, or database review will benefit from access to these resources and Roche staff skilled in clinical research.

· 
Previous fellows have thoroughly enjoyed their experience, gained valuable knowledge and contacts and opportunities to further their careers

· 
Times Top 100 Best Companies to Work for 2020

Application Process

Phase I:

Purpose - our focus on this first stage is to understand why you have applied for this role and what you will bring to the role to ensure team and personal success.

· 
Cover letter & CV

· 
Video interview

As part of your cover letter, Roche is keen to understand your motivation in applying for this position. You should, therefore, provide responses to the following:

· 
Why Roche : What do you know about Roche and why do you want to work here?

· 
Why you : What is thestand out achievementin your life that you feel makes you suitable for this role and why?

Your cover letter should not exceed one page.

** note any application without a cover letter will be automatically rejected. **

Phase II:

· 
Final Assessment Centre

Check out application tips and tricks HERE :

https://www.roche.com/careers/our-locations/europe/unitedkingdom/early-careers-uk-generationext/apply-whats-next.htm

For 2020/21, the Roche Oncology Clinical Development Group will select one Clinical Research Fellow through a competitive application process. The application window will close at midnight January 2nd.

Roche is an equal opportunity employer.
Medical Affairs, Medical Affairs > Medical Information/Scientific Affairs

·  Who we are

At Roche, 98,000 people across 100 countries are pushing back the frontiers of healthcare. Working together, we've become one of the world's leading research-focused healthcare groups. Our success is built on innovation, curiosity and diversity.

Roche is an equal opportunity employer and strictly prohibits unlawful discrimination based upon an individual's race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, mental/physical disability, medical condition, marital status, veteran status, or any other characteristic protected by law.